Skip to main content
Clinical Trials/NL-OMON43868
NL-OMON43868
Completed
Not Applicable

ow-flow extracorporeal CO2 removal in patients with moderate ARDS to enhance lung protective ventilation. Pilot feasibility and safety study - SUPERNOVA

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ARDS
Sponsor
European Society of Intensive Care Medicine (ESICM)
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- moderately severe ARDS according to the Berlin definition(16\);PaO2/FiO2: 200\-100 mmHg, with PEEP \* 5 cmH2O
  • \- expected duration of ventilation \>24h

Exclusion Criteria

  • \- Age \<18 years
  • \- Pregnancy
  • \- Decompensated heart insufficiency or acute coronary syndrome \- Severe COPD
  • \- Major respiratory acidosis PaCO2\>60 mmHg
  • \- Acute brain injury
  • \- Severe liver insufficiency (Child\-Pugh scores \>7\) or fulminant hepatic failure
  • \- Heparin\-induced thrombocytopenia (HIT)
  • \- Contraindication for systemic anticoagulation
  • \- Patient moribund, decision to limit therapeutic interventions
  • \- Catheter access to femoral vein or jugular vein impossible

Outcomes

Primary Outcomes

Not specified

Similar Trials